GLP-1 RA antiobesity medications: a new panacea?

Patients are seeing improvements in body mass index and overall health when they take the new GLP-1 RA antiobesity medications. These drugs are not a cure-all, but they are effective and are shifting medicine to study the gut-brain axis and how it affects human health. Here’s an explanation by Robert Kushner, MD, who has made a career as a researcher and author about overweight, obesity and nutrition. He’s also a doctor who has treated patients for years through Northwestern University’s Feinberg School of Medicine and Northwestern Medicine’s Center for Lifestyle Medicine.